All News & Stories

May 13, 2020

Geneva scientist part of international consortium targeting lethal viruses including coronavirus with antibody therapies

With research from filoviruses and hantaviruses underway, Dr. Andrew Herbert hopes to chart a similar path for SARS-CoV-2.   Andrew Herbert, PhD, a senior research scientist for The Geneva Foundation, is part of an international consortium of over 20 investigators from across the globe who recognized the immediate need to address the COVID-19 pandemic early

Read more
April 30, 2020

4D Bio3 Program Completes First 3D Bioprinting Test Experiment in Space

The 3D BioFabrication Facility (BFF) was launched in mid-2019 and marks the first-ever 3D printer capable of manufacturing human tissue (including, someday, organs) in microgravity.   The Geneva Foundation (Geneva), in partnership with the Uniformed Services University of the Health Sciences (USU), commercial space company TechShot, Inc, and 3D printer manufacturer nScrypt, Inc., have successfully

Read more
April 25, 2020

Combating Malaria

Geneva proudly helps military researchers find new treatments for some of the world’s deadliest and most difficult to treat infectious diseases. Malaria infects approximately 228 million people with approximately 405,000 deaths annually. Approximately 67% of those deaths were children under the age of five in 2018. According to the World Health Organization’s 2019 World Malaria

Read more
April 24, 2020

FOXTROT project and Geneva researcher recognized for achievements in improving ophthalmic trauma care

Researchers at Telemedicine and Advanced Technology Research Center’s (TATRC) Mobile Health Innovation Center (mHIC), supported by Geneva, are advancing traditional communication mechanisms to improve care coordination between patients and providers in ophthalmic trauma care. The Forward Operating Base Expert Telemedicine Resource Utilizing Mobile Application for Trauma (FOXTROT) study is led by Principal Investigator (PI) MAJ

Read more
April 20, 2020

MIRROR Program’s Pain Management Expertise Sought in Response to COVID-19 Pandemic

Best practices for pain medicine physicians during COVID-19 featured on cover of ‘Pain Medicine’, the official journal of the American Academy of Pain Medicine   Dr. Steven P. Cohen, an investigator for the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) program, and his colleagues were asked to provide best pain management practices during the

Read more
April 2, 2020

A Letter from President & CEO Elise W. Huszar on COVID-19

To Geneva’s partners and collaborators: As The Geneva Foundation (Geneva) responds to COVID-19, the health and safety of our employees and partners continues to be our top priority. Geneva’s work in advancing groundbreaking and impactful medical research is vital to the health and safety of millions of people around the world, and we remain committed

Read more
March 18, 2020

Geneva Strengthens Board with New Members

Ross Colt, MD, MBA, FAAFP (left) and John Hornick, JD (right) joined Geneva’s Board of Directors to lend their expertise in support of Geneva’s mission to advance military medicine. Dr. Colt is the Medical Director for Gary and Mary West PACE, a non-profit clinic that unites the delivery of medical, social, and behavioral services to

Read more
February 27, 2020

4D Bio3 Improves Battlefield Care

Geneva’s 4D Bio3  program, in collaboration with Uniformed Services University, Safi Biosolutions, Sciperio, Advanced Bioprocess Services, Massachusetts General Hospital, Harvard Medical School, and the Food and Drug Administration, launched the 4D Bio3 On-Demand Blood Program to deliver on-demand blood and revolutionize military trauma care. Blood transfusions used in trauma care are currently obtained from human

Read more